Department of Pharmacology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
J Neurochem. 2012 Mar;120(6):1036-47. doi: 10.1111/j.1471-4159.2011.07628.x. Epub 2012 Feb 6.
To examine mechanisms underlying substance P (SP) release from primary sensory neurons in response to activation of the non-selective cation channel transient receptor potential ankyrin 1 (TRPA1), SP release from cultured rat dorsal root ganglion neurons was measured, using radioimmunoassay, by stimulating TRPA1 with allyl isothiocyanate (AITC), a TRPA1 agonist. AITC-evoked SP release occurred in a concentration- and time-dependent manner. Interestingly, p38 mitogen-activated protein kinase (p38) inhibitor SB203580 significantly attenuated AITC-evoked SP release. The in vivo effect of AITC-evoked SP release from primary sensory neurons in mice was evaluated. Hind paw intraplantar injection of AITC induced nociceptive behaviors and inflammation (edema, thermal hyperalgesia). AITC-induced thermal hyperalgesia and edema were inhibited by intraplantar pre-treatment with either SB203580 or neurokinin-1 receptor antagonist CP96345. Moreover, intrathecal pre-treatment with either CP96345 or SB203580 inhibited AITC-induced nociceptive behaviors and thermal hyperalgesia. Immunohistochemical studies demonstrated that intraplantar AITC injection induced the phosphorylation of p38 in mouse dorsal root ganglion neurons containing SP. These findings suggest that activation of TRPA1 evokes SP release from the primary sensory neurons through phosphorylation of p38, subsequent nociceptive behaviors and inflammatory responses. Furthermore, the data also indicate that blocking the effects of TRPA1 activation at the periphery leads to significant antinociception.
为了研究物质 P(SP)从初级感觉神经元中释放的机制,以响应非选择性阳离子通道瞬时受体电位锚蛋白 1(TRPA1)的激活,使用放射免疫测定法测量了培养的大鼠背根神经节神经元中 SP 的释放,通过用丙烯基异硫氰酸酯(AITC)刺激 TRPA1,TRPA1 激动剂。AITC 诱导的 SP 释放呈浓度和时间依赖性。有趣的是,p38 丝裂原活化蛋白激酶(p38)抑制剂 SB203580 显著减弱了 AITC 诱导的 SP 释放。评估了 AITC 从初级感觉神经元中诱导的 SP 释放对体内的影响。足底内注射 AITC 诱导伤害性行为和炎症(水肿,热痛觉过敏)。足底内预先用 SB203580 或神经激肽-1 受体拮抗剂 CP96345 预处理可抑制 AITC 诱导的热痛觉过敏和水肿。此外,鞘内预先用 CP96345 或 SB203580 预处理可抑制 AITC 诱导的伤害性行为和热痛觉过敏。免疫组织化学研究表明,足底内注射 AITC 诱导含有 SP 的小鼠背根神经节神经元中 p38 的磷酸化。这些发现表明,TRPA1 的激活通过 p38 的磷酸化引起初级感觉神经元中 SP 的释放,随后引起伤害性行为和炎症反应。此外,数据还表明,在外周阻断 TRPA1 激活的作用可导致明显的镇痛作用。